Endotoxin testing is a crucial element of pharma companies’ contamination control strategies, with significant patient safety, product quality and manufacturing process implications.
Amid growing pressure on pharma manufacturers to take a more sustainable approach to their endotoxin tests and drastically reduce their reliance on finite natural resources, this session will discuss:
- Advances in endotoxin testing
- Successfully switching to non-animal reagents and assays
- Tackling speed, cost and complexity in endotoxin testing
